Business Process Outsourcing

PRODUCTS

  • Navigating both the specific country and general European regulations and requirements to supply medicinal products to the European markets can be a complex challenge. This applies both to Marketing Authorisation Holders (MAH) of approved commercial medicinal products and Sponsors of clinical trials.

  • From precise edits to robust expression, get iPSC genome editing done right — from the experienced innovators in gene editing and iPSC technology.

  • This easy-to-use process analytical technology device offers in-line bioprocess analysis and control with no complex modeling. Measure multiple critical parameters across media, across processes, across mammalian cell lines, across scales.

    All In-line Gain, No Modeling Pain

    MAVERICK is powered by Raman spectroscopy and a purpose-built de novo model. The de novo model is explicitly built on media chemistries and device physics, not on empirical data. It automatically interprets the spectra and quantifies process parameters enabling simultaneous measurements of glucose, lactate, and total biomass. This is achieved without the costs, complexities, and risks associated with conventional Process Analytical Technology (PAT) methods. There is no need to grapple with complex empirical models, reagents, or unreliable auto-sampling systems to implement in-line bioprocess analysis.

  • Discover how a collaborative approach to medical writing ensures the highest standards of excellence and precision in every document produced.

  • The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.

    Avance Clinical, a global CRO with more than 3 decades of experience, has an impressive track record in the US with over 200 US studies including 140 in oncology.

WHITE PAPERS AND CASE STUDIES

NEWS